USFDA concludes pre-approval inspection at Torrent Pharmaceuticals’ Gujarat facility

20 Mar 2023 Evaluate

The United States Food and Drug Administration (USFDA) has concluded Pre-Approval Inspection (PAI) at Torrent Pharmaceuticals’ Oral-Oncology manufacturing facility at Bileshwarpura, Gujarat from March 13, 2023 to March 17, 2023. At the end of the inspection, the company has been issued a ‘Form 483’ with 1 observation, which is procedural in nature.

Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

4051.50 -39.30 (-0.96%)
20-Jan-2026 09:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.90
Dr. Reddys Lab 1165.00
Cipla 1385.95
Zydus Lifesciences 882.75
Lupin 2173.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×